| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/13/2005 | CN1606569A Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 04/13/2005 | CN1606568A Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 04/13/2005 | CN1606566A Integrin targeting compounds |
| 04/13/2005 | CN1606560A Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, their use and pharmaceutical compositions containing same |
| 04/13/2005 | CN1606555A Imidazoquinoline derivatives |
| 04/13/2005 | CN1606554A Beta-lactamyl vasopressin v1aantagonists |
| 04/13/2005 | CN1606552A Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| 04/13/2005 | CN1606550A Benzothia(dia)zine derivatives and their use as AMPA modulators |
| 04/13/2005 | CN1606549A Thiazolidine derivative and medicinal use thereof |
| 04/13/2005 | CN1606544A Bicyclic compound |
| 04/13/2005 | CN1606463A Methods of treating bacterial infections in dogs and cats |
| 04/13/2005 | CN1606451A Remedies and/or preventives for conformational diseases |
| 04/13/2005 | CN1606450A Polypeptide, the conjugate thereof with doxorubicin and a pharmaceutical composition based thereon |
| 04/13/2005 | CN1606449A Improved use of antitumoral compound in cancer therapy |
| 04/13/2005 | CN1606444A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/13/2005 | CN1606443A Substituted diketopiperazines as oxytocin antagonists |
| 04/13/2005 | CN1606441A Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 04/13/2005 | CN1606440A Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them |
| 04/13/2005 | CN1606439A Cis-imidazolines |
| 04/13/2005 | CN1606438A 5HT4 partial agonist pharmaceutical compositions |
| 04/13/2005 | CN1606435A Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
| 04/13/2005 | CN1605590A 10 peptide with cell protection function |
| 04/13/2005 | CN1605354A Yang strengthening capsule and its preparation |
| 04/13/2005 | CN1196714C Process for producing immunolobulins for intravenous administration and other immunolobulin products |
| 04/13/2005 | CN1196704C Process for preparing inhibitors of nucleoside metabolism |
| 04/13/2005 | CN1196696C New thiochromane derivatives and use as thrombin inhibitors |
| 04/13/2005 | CN1196692C Substituted benzopyran derivatives for the treatment of inflammation |
| 04/13/2005 | CN1196687C Inhibitors of IMPDH enzyme |
| 04/13/2005 | CN1196685C Pyrimidine derivatives |
| 04/13/2005 | CN1196682C 4-pyridinyl-N-acyl-L-phenylalanines |
| 04/13/2005 | CN1196681C (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers |
| 04/13/2005 | CN1196680C Modulators of dopamine neurotransmission |
| 04/13/2005 | CN1196671C Mono-and-disubstituted 2-pyrolyl gamma-aminobutric acids |
| 04/13/2005 | CN1196488C Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 04/13/2005 | CN1196487C 单位剂量形式 The unit dosage form |
| 04/13/2005 | CN1196483C Compositions for improivng fertility |
| 04/13/2005 | CN1196482C Use of anticonvulsant derivatives for treating bulimia nervosa |
| 04/13/2005 | CN1196481C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/13/2005 | CN1196474C Liposome-entrapped DNA oral vaccines |
| 04/12/2005 | US6878826 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof |
| 04/12/2005 | US6878819 Oligosaccharides or oligosaccharide containing compounds, especially N-acetyl-chitooligosaccharides, which are fucosylated with donar nucleotide sugar containing L-fucose such as guanosine diphosphate-L-fucose |
| 04/12/2005 | US6878813 Elastase-resistant antithrombin III (ATIII) for treating blood clotting disorders |
| 04/12/2005 | US6878808 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 04/12/2005 | US6878745 Selective preventives/remedies for progressive lesions after organ damage |
| 04/12/2005 | US6878742 Alzheimer's disease; Down's syndrome |
| 04/12/2005 | US6878739 Composition for treating or preventing glomerulopathy |
| 04/12/2005 | US6878736 Histamine H3 receptor ligands |
| 04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
| 04/12/2005 | US6878727 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 04/12/2005 | US6878725 Serine protease inhibitors |
| 04/12/2005 | US6878723 Carbocyclic and/or heterocyclic amino carboxylic acids, e.g., 2-aminomethyl-6-(p-benzylphenoxy)hexanoic acid; leukotriene A4 hydrolase; treating arthritis and psoriasis; hematoprotective and antimitotic agents |
| 04/12/2005 | US6878721 Beta2-adrenoceptor agonists |
| 04/12/2005 | US6878720 VEGF receptor tyrosine kinase inhibitors |
| 04/12/2005 | US6878718 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/12/2005 | US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer |
| 04/12/2005 | US6878711 Indole derivatives as PDE5-inhibitors |
| 04/12/2005 | US6878709 Treating acute and chronic inflammatory disorders and cancer. |
| 04/12/2005 | US6878705 Especially agents against viruses of the herpes family. |
| 04/12/2005 | US6878702 Anti-inflammatory agents |
| 04/12/2005 | US6878690 Compounds and methods |
| 04/12/2005 | US6878525 Peptide leukotriene receptor |
| 04/12/2005 | US6878522 Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
| 04/12/2005 | CA2356065C Phenoxyphenylheterocycle derivatives as ssris |
| 04/12/2005 | CA2203936C Boronic ester and acid compounds, synthesis and uses |
| 04/12/2005 | CA2194471C Bis-piperidinyl non-peptidyl tachykinin receptor antagonist |
| 04/12/2005 | CA2178783C Zilpaterol chlorhydrate with a specific cristalline structure, process for preparing the same and intermediates used therefor |
| 04/12/2005 | CA2131229C Bisconjugates comprising two saccharides and a spacer |
| 04/12/2005 | CA2122571C Adhesion receptor antagonists |
| 04/12/2005 | CA2081836C Aromatic amidine derivatives and salts thereof |
| 04/07/2005 | WO2005030773A1 Novel pyrazolopyrimidine derivatives |
| 04/07/2005 | WO2005030740A1 Thiazoline derivative and use of the same |
| 04/07/2005 | WO2005030723A1 Pyridylacetylenes for use as radiotracers and imaging agents |
| 04/07/2005 | WO2005030720A1 Piperidine derivative having nmda receptor antagonistic activity |
| 04/07/2005 | WO2005030706A1 Amide type carboxamide derivative |
| 04/07/2005 | WO2005030329A1 Method of damaging biomolecule and biomolecule damaging apparatus |
| 04/07/2005 | WO2005030236A1 Substance having intrahepatic glyconeogenesis inhibiting activity and food or food additive containing the substance |
| 04/07/2005 | WO2005030211A1 Aerosol formulation for inhalation, containing an anticholinergic agent |
| 04/07/2005 | WO2005012269A8 Novel azole compound |
| 04/07/2005 | WO2005000195A3 A pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger |
| 04/07/2005 | WO2004096818A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 04/07/2005 | WO2004089369A3 Methods and means for treating protein conformational disorders |
| 04/07/2005 | WO2004073741A8 Remedy for spinal injury containing interleukin-6 antagonist |
| 04/07/2005 | WO2004013309A3 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 04/07/2005 | WO2004006847A3 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 04/07/2005 | WO2004002422A3 2’-c-methyl-3’-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 04/07/2005 | US20050076398 Lysine starve rodent model for identifying modulators for treartment and prevention of gastrointestinal disorders |
| 04/07/2005 | US20050075516 Anticarcinogenic agents formed by phosphorylation |
| 04/07/2005 | US20050075489 DSP-5 dual-specificity phosphatase |
| 04/07/2005 | US20050075480 Urotensin-II agonists and antagonists |
| 04/07/2005 | US20050075397 Composition comprising at least one alkanolamide for inhibiting langerhans cells migration, and uses thereof |
| 04/07/2005 | US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases |
| 04/07/2005 | US20050075391 Nitric oxide donor composition and method for treatment of anal disorders |
| 04/07/2005 | US20050075386 Drugs from indocasbazole derivatives |
| 04/07/2005 | US20050075380 Composition comprising at least one oxazolin for inhibiting langerhans cell migratio, and uses thereof |
| 04/07/2005 | US20050075378 Modulators of peroxisome proliferator activated receptors (ppar) |
| 04/07/2005 | US20050075377 Compounds for elevating plasma lipid levels with prodrugs for humans and other mammals |
| 04/07/2005 | US20050075373 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/07/2005 | US20050075356 E.g., N-(4-fluorobenzyl)-5,6-dihydroxy-2-[1-methyl-1-(methylamino)ethyl]pyrimidine-4-carboxamide, used for preventing, treating or delaying the onset of and infection by AIDS |
| 04/07/2005 | US20050075349 Xanthine phosphodiesterase V inhibitors |
| 04/07/2005 | US20050075346 Novel compounds |